Related Experiment Videos
Circulating ICAM-1 levels in children with atopic dermatitis
Summary
Intercellular adhesion molecule-1 (ICAM-1) levels increase with atopic dermatitis severity. Higher ICAM-1 serum levels correlate with disease extent, suggesting it reflects inflamed tissue in atopic dermatitis patients.
Area of Science:
- Immunodermatology
- Biomarker Discovery
- Inflammation Research
Background:
- Atopic dermatitis is a common inflammatory skin condition.
- Intercellular adhesion molecule-1 (ICAM-1) is implicated in inflammatory processes.
Purpose of the Study:
- To investigate the correlation between serum ICAM-1 levels and atopic dermatitis severity.
- To explore the relationship between ICAM-1, eosinophilic cationic protein, and eosinophil counts in atopic dermatitis.
Main Methods:
- Measurement of serum ICAM-1 levels in 48 atopic dermatitis patients (mild, moderate, severe) and 32 controls.
- Correlation analysis between ICAM-1, eosinophilic cationic protein, and peripheral eosinophil counts.
- Assessment of ICAM-1 level changes after 3 months of ketotifen treatment in ten patients.
Main Results:
- Serum ICAM-1 levels showed a significant positive correlation with atopic dermatitis severity (mild, moderate, severe).
- A strong correlation was found between serum ICAM-1 and eosinophilic cationic protein (r = .71, P < .01).
- Serum ICAM-1 levels significantly correlated with disease severity after treatment (r = .76, P < .01).
Conclusions:
- Serum ICAM-1 levels may serve as a valuable biomarker for the extent of inflamed tissue in atopic dermatitis.
- ICAM-1 levels correlate with disease severity and inflammatory markers in atopic dermatitis.